Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1991 2
1992 2
1994 2
1998 1
1999 2
2000 1
2004 2
2005 1
2007 1
2008 1
2009 2
2010 3
2011 3
2012 2
2013 3
2015 4
2016 4
2017 9
2018 15
2019 13
2020 17
2021 16
2022 13
2023 7
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial.
Ebata S, Yoshizaki A, Oba K, Kashiwabara K, Ueda K, Uemura Y, Watadani T, Fukasawa T, Miura S, Yoshizaki-Ogawa A, Asano Y, Okiyama N, Kodera M, Hasegawa M, Sato S. Ebata S, et al. Lancet Rheumatol. 2021 Jul;3(7):e489-e497. doi: 10.1016/S2665-9913(21)00107-7. Epub 2021 May 26. Lancet Rheumatol. 2021. PMID: 38279402
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): open-label extension of a double-blind, investigators-initiated, randomised, placebo-controlled trial.
Ebata S, Yoshizaki A, Oba K, Kashiwabara K, Ueda K, Uemura Y, Watadani T, Fukasawa T, Miura S, Yoshizaki-Ogawa A, Okiyama N, Kodera M, Hasegawa M, Sato S. Ebata S, et al. Lancet Rheumatol. 2022 Aug;4(8):e546-e555. doi: 10.1016/S2665-9913(22)00131-X. Epub 2022 Jun 28. Lancet Rheumatol. 2022. PMID: 38294008 Clinical Trial.
Interleukin-17 pathway inhibition with brodalumab in early systemic sclerosis: Analysis of a single-arm, open-label, phase 1 trial.
Fukasawa T, Yoshizaki A, Ebata S, Fukayama M, Kuzumi A, Norimatsu Y, Matsuda KM, Kotani H, Sumida H, Yoshizaki-Ogawa A, Kagebayashi H, Sato S. Fukasawa T, et al. Among authors: ebata s. J Am Acad Dermatol. 2023 Aug;89(2):366-369. doi: 10.1016/j.jaad.2023.02.061. Epub 2023 Mar 29. J Am Acad Dermatol. 2023. PMID: 36997069 Free article. Clinical Trial. No abstract available.
Involvement of B cells in the development of systemic sclerosis.
Yoshizaki A, Fukasawa T, Ebata S, Yoshizaki-Ogawa A, Sato S. Yoshizaki A, et al. Among authors: ebata s. Front Immunol. 2022 Jul 28;13:938785. doi: 10.3389/fimmu.2022.938785. eCollection 2022. Front Immunol. 2022. PMID: 35967355 Free PMC article. Review.
Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis.
Kuzumi A, Yoshizaki A, Matsuda KM, Kotani H, Norimatsu Y, Fukayama M, Ebata S, Fukasawa T, Yoshizaki-Ogawa A, Asano Y, Morikawa K, Kazoe Y, Mawatari K, Kitamori T, Sato S. Kuzumi A, et al. Among authors: ebata s. Nat Commun. 2021 Oct 12;12(1):5947. doi: 10.1038/s41467-021-26099-w. Nat Commun. 2021. PMID: 34642338 Free PMC article.
Significance of anti-transcobalamin receptor antibodies in cutaneous arteritis revealed by proteome-wide autoantibody screening.
Matsuda KM, Kotani H, Yamaguchi K, Okumura T, Fukuda E, Kono M, Hisamoto T, Kawanabe R, Norimatsu Y, Kuzumi A, Fukayama M, Fukasawa T, Ebata S, Yoshizaki-Ogawa A, Okamura T, Shoda H, Fujio K, Goshima N, Sato S, Yoshizaki A. Matsuda KM, et al. Among authors: ebata s. J Autoimmun. 2023 Feb;135:102995. doi: 10.1016/j.jaut.2023.102995. Epub 2023 Jan 30. J Autoimmun. 2023. PMID: 36724643 Free article.
Japanese Orthopaedic Association (JOA) clinical practice guidelines on the management of lumbar disc herniation, third edition - secondary publication.
Haro H, Ebata S, Inoue G, Kaito T, Komori H, Ohba T, Sakai D, Sakai T, Seki S, Shiga Y, Suzuki H, Toyota H, Watanabe K, Yamato Y. Haro H, et al. Among authors: ebata s. J Orthop Sci. 2022 Jan;27(1):31-78. doi: 10.1016/j.jos.2021.07.028. Epub 2021 Dec 2. J Orthop Sci. 2022. PMID: 34865915 Review. No abstract available.
115 results